sb 203580 has been researched along with 3-hydroxy-5-oxo-5,6-secocholestan-6-al in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (3-hydroxy-5-oxo-5,6-secocholestan-6-al) | Trials (3-hydroxy-5-oxo-5,6-secocholestan-6-al) | Recent Studies (post-2010) (3-hydroxy-5-oxo-5,6-secocholestan-6-al) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 14 | 0 | 5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Achuthan, V; D'Auvergne, O; Laynes, L; Raghavamenon, AC; Uppu, RM | 1 |
1 other study(ies) available for sb 203580 and 3-hydroxy-5-oxo-5,6-secocholestan-6-al
Article | Year |
---|---|
MAPK signaling in H9c2 cardiomyoblasts exposed to cholesterol secoaldehyde--role of hydrogen peroxide.
Topics: Apoptosis; Cell Line; Cholestanones; Humans; Hydrogen Peroxide; Imidazoles; Mitogen-Activated Protein Kinase Kinases; Myoblasts, Cardiac; Pyridines; Reactive Oxygen Species; Secosteroids; Stress, Physiological | 2011 |